Your browser doesn't support javascript.
loading
Pembrolizumab plus lenvatinib in second-line and third-line patients with pleural mesothelioma (PEMMELA): a single-arm phase 2 study.
Douma, Li-Anne H; Lalezari, Ferry; van der Noort, Vincent; de Vries, Jeltje F; Monkhorst, Kim; Smesseim, Illaa; Baas, Paul; Schilder, Bodien; Vermeulen, Marrit; Burgers, Jacobus A; de Gooijer, Cornedine J.
Affiliation
  • Douma LH; Department of Thoracic Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands.
  • Lalezari F; Department of Radiology, Netherlands Cancer Institute, Amsterdam, Netherlands.
  • van der Noort V; Department of Biometrics, Netherlands Cancer Institute, Amsterdam, Netherlands.
  • de Vries JF; Department of Biometrics, Netherlands Cancer Institute, Amsterdam, Netherlands.
  • Monkhorst K; Department of Pathology, Netherlands Cancer Institute, Amsterdam, Netherlands.
  • Smesseim I; Department of Thoracic Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands.
  • Baas P; Department of Thoracic Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands.
  • Schilder B; Department of Thoracic Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands.
  • Vermeulen M; Department of Biometrics, Netherlands Cancer Institute, Amsterdam, Netherlands.
  • Burgers JA; Department of Thoracic Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands. Electronic address: s.burgers@nki.nl.
  • de Gooijer CJ; Department of Thoracic Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands.
Lancet Oncol ; 24(11): 1219-1228, 2023 Nov.
Article in En | MEDLINE | ID: mdl-37844598
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pleural Neoplasms / Antineoplastic Agents, Immunological / Mesothelioma, Malignant / Mesothelioma Limits: Adolescent / Adult / Aged / Female / Humans / Male Language: En Journal: Lancet Oncol Journal subject: NEOPLASIAS Year: 2023 Document type: Article Affiliation country: Países Bajos Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pleural Neoplasms / Antineoplastic Agents, Immunological / Mesothelioma, Malignant / Mesothelioma Limits: Adolescent / Adult / Aged / Female / Humans / Male Language: En Journal: Lancet Oncol Journal subject: NEOPLASIAS Year: 2023 Document type: Article Affiliation country: Países Bajos Country of publication: Reino Unido